Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid

    • Product Name Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid
    • Alias Fmoc-4F-Phe(S)-β-homo-OH
    • Einecs 846-787-7
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    416089

    Product Name Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid
    Cas Number 2140051-71-1
    Molecular Formula C24H20FNO4
    Molecular Weight 405.42 g/mol
    Purity ≥98%
    Appearance White to off-white solid
    Optical Purity ≥98% ee
    Storage Temperature 2-8°C
    Solubility Soluble in DMSO, DMF, and common organic solvents
    Protecting Group Fmoc

    As an accredited Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing White, sealed HDPE bottle containing 5 grams of Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid, with tamper-evident cap and hazard labeling.
    Shipping Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid is shipped in secure, airtight containers, protected from moisture and light. Chemical shipments comply with all relevant regulations, including appropriate labeling and documentation. Standard shipment is via express courier, with temperature control if required, ensuring safe and prompt delivery to academic, research, or industrial destinations.
    Storage Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid should be stored in a tightly sealed container at 2–8°C (refrigerated), protected from light and moisture. The chemical should be kept in a cool, dry place, away from incompatible substances and direct sunlight to avoid degradation. Avoid excessive heat and ensure proper ventilation in the storage area.
    Application of Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid

    Applications of Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid in Industrial Manufacturing

    Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid plays a critical role as a chiral building block in specialized sectors within the pharmaceutical and biotechnological industries. As a direct manufacturer, we supply this material to discerning customers focusing on demanding downstream formulations and processes. Below, we detail specific industrial application scenarios, compliance standards, handling ratios, integration points, and typical finished product types in each field.

    1. Peptide Drug Synthesis for Oncology Candidates

    Pharmaceutical companies utilize this compound for the stepwise synthesis of fluorinated peptide drug candidates, especially when targeting kinase inhibitor classes or tumor microenvironment modulation. It facilitates the introduction of fluoroaromatic side chains to optimize pharmacokinetic properties in investigational anti-cancer peptides. Customers require consistent stereochemistry, traceable documentation, and tight control over isomeric purity to meet regulatory milestones in clinical drug development.

    Industry compliance standards

    • ICH Q7 GMP for active pharmaceutical ingredient manufacturing
    • FDA 21 CFR Part 211 for finished pharmaceuticals
    • USP <1049> on peptide mapping
    • EMA Guidelines for synthetic peptides

    Typical usage ratio

    • Employ at 0.3–1.5 molar equivalents per coupling cycle, adjusted for chain length and target yield

    Downstream process integration

    • Integrate during solid-phase peptide synthesis, directly after Fmoc deprotection step, in the core elongation cycles using automated synthesizers

    Final product types

    • Tumor-targeting peptide therapeutic APIs
    • Preclinical research-grade peptide libraries
    • Advanced intermediate peptides for clinical studies
    • Reference standards for oncology compound analytical validation

    2. Custom Peptidomimetic Scaffold Production

    Biotechnology firms use this raw material to construct peptidomimetic scaffolds with improved metabolic stability for lead optimization. The (S)-3-amino configuration and fluorinated aromatic group enhance backbone conformational restriction, supporting the generation of protease-resistant analogues. Production batches require batch-release documentation and structural verification by NMR and HPLC at each process stage.

    Industry compliance standards

    • ISO 9001:2015 for chemical synthesis
    • OECD Good Laboratory Practice (GLP) for nonclinical safety testing
    • Ph. Eur. 10.0 section 2.2.46 on peptide analysis
    • REACH regulation (EC) No 1907/2006 for chemical registration

    Typical usage ratio

    • 1–2 molar equivalents per scaffold assembly; precise value depends on scaffold size and functionalization demand

    Downstream process integration

    • Add during the chain-elongation of solution-phase peptidomimetic assembly after Fmoc group removal, preceding specific cyclization or side chain modification steps

    Final product types

    • Preclinical peptidomimetic agents for enzyme inhibition assays
    • Lead compounds for structure–activity relationship (SAR) evaluation
    • Stable analogues for metabolic stability testing
    • Targeted library synthesis for high-throughput screening

    3. Manufacturing of Fluorinated Amino Acid Reference Standards

    Analytical laboratories and QC departments of pharmaceutical companies rely on this material to prepare high-purity reference standards for method development and validation of fluorinated peptide APIs. Rigorous documentation, impurity profiling, and analytical batch traceability remain essential for audit compliance and regulatory submission.

    Industry compliance standards

    • USP <621> Chromatography for analytical validation
    • ISO/IEC 17025 for laboratory competence
    • FDA guidelines for analytical method validation
    • ICH Q2(R1) Validation of analytical procedures

    Typical usage ratio

    • Prepare as neat standards or in 1–10 mg/mL DMSO solutions; concentration adjusted for detector calibration and limit of quantification requirements

    Downstream process integration

    • Synthesize at precise scale, typically by batchwise solution-phase chemistry, followed by preparative HPLC purification and documentation for shipment as certified reference standards

    Final product types

    • Certified reference standards for LC-MS and HPLC peptide assay calibration
    • In-house analytical controls for release testing
    • Impurity profile references for regulatory filings
    • System suitability test compounds for QC instrumentation

    4. Production of Chiral Pharmaceutical Intermediates

    Manufacturing operations for small-molecule pharmaceuticals sometimes require fluorinated chiral amino acid intermediates as key starting materials, especially for central nervous system (CNS) and antidiabetic drug classes. The (S)-configuration and protecting group integrity are vital for downstream coupling, amidation, or cyclization steps that demand traceable source and reproducible stereochemistry.

    Industry compliance standards

    • EU GMP Part II for starting material control
    • Chinese Pharmacopeia (ChP) for chiral building blocks
    • FDA DMF (Type II) registration for raw material suppliers
    • ICH Q11 guidance on drug substance development

    Typical usage ratio

    • Utilize between 10–25% w/w with respect to the overall intermediate synthesis mass; optimize according to target molecule complexity and step efficiency

    Downstream process integration

    • Introduce in solution or solid-phase assembly as a key amine or acid coupling partner for constructing advanced fluorinated intermediates; control order of addition and pH for efficient conversion

    Final product types

    • Regioselectively fluorinated CNS active intermediates
    • Chiral carbamate-protected drug core fragments
    • Advanced pharmaceutical intermediates for API finishing sites
    • Developmental compounds for regulatory toxicology studies

    5. Peptide Cosmetic Ingredient Manufacturing

    Specialty cosmetic manufacturers use fluorinated amino acids to provide unique functionalities such as skin penetration enhancement or improved peptide stability in topical formulations. Consistent color index, heavy metal specification, and microbial limits are essential to comply with cosmetic raw material guidelines and ensure suitability for skin-contact formulations.

    Industry compliance standards

    • ISO 22716:2007 Good Manufacturing Practices for cosmetics
    • EU Cosmetic Regulation (EC) No 1223/2009
    • Safety assessment guidelines per SCCS/1602/18
    • Microbial and heavy metals limit per national cosmetic standards (e.g., GB 7916-1987 in China)

    Typical usage ratio

    • Incorporate at 0.2–2% by weight in peptide ingredient blends; adjust based on targeted cosmetic efficacy and compatibility

    Downstream process integration

    • Add to peptide synthesis sequence for cosmetic active production or blend as a finished ingredient with excipients under controlled environmental conditions and monitored for stability

    Final product types

    • Stabilized bioactive peptide components for cosmeceuticals
    • Fluorinated amino acid-containing anti-aging formulas
    • Skin-rejuvenation peptides for topical application
    • Premium skincare peptide active ingredients
    Free Quote

    Competitive Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Introducing Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid: A Fresh Perspective from the Factory Floor

    Experience Behind Every Batch

    Working day-to-day with Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid, I’ve come to appreciate the discipline, precision, and collective know-how poured into every flask and reactor tank. Building this compound by hand, step by step, keeps our focus sharp and makes every improvement in our process translate directly to our customers. This product comes from a blend of longstanding organic synthesis skills and ongoing investments in modern equipment. Over the years, teams of chemists and operators have learned which conditions produce clean coupling, how to filter out trace impurities, and ways to keep the Fmoc protection intact until our customers are ready to take it off.

    Understanding the Molecular Details

    Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid stands apart from simpler α-amino acids and the more routine Fmoc-protected building blocks. Structurally, it features a butyric acid backbone lengthened by an extra carbon, a side-chain amine in the S configuration, and a distinct 4-fluoro-phenyl ring. Adding the Fmoc group demands careful reaction control—we use validated conditions to achieve high attachment rates without over-protecting or accidentally oxidizing the core structure. The result is a solid, white powder with well-defined purity profiles, typically exceeding 98 percent by HPLC and confirmed by NMR and mass spectrometry.

    Spec Sheets Reveal Truth, but Experience Tells More

    Hunting for paperwork on Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid? Spec sheets can tally purity and melting points, but years of monitoring reactions have taught me more than any document. Packing each lot involves direct observation—appearance, odor, how it flows and clumps. Differences between this and similar Fmoc amino acids become clear under the hood. For example, the 4-fluoro-phenyl moiety needs extra vigilance during hydrogenation; skipping even minor adjustments can compromise both the yield and the downstream peptide synthesis. We keep trouble from reaching our customers by learning from every deviation and tuning our filtration steps to remove those pesky side products particular to this analog.

    Every Application Has a Story

    Pharmaceutical and peptide labs ask us for Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid for just one main reason: function. This building block introduces a rare fluorinated aromatic group into a growing chain. Experienced peptide chemists know the effect—improved biological stability, subtle electronic modulations at the binding site, and sometimes increased resistance against metabolic degradation. We’ve tracked feedback from synthetic teams worldwide. When they need this specific eluent to build new peptidomimetic drugs or probe receptor interactions, providing a robust, reproducible source saves time and rework. We listen to direct user feedback and refine our crystalization, drying, and storage—not because a spec sheet demands it, but because a human voice pointed us in the right direction.

    Production Lessons Earned, Not Borrowed

    Lab syntheses described in journals form the blueprint, but plant-scale production challenges every assumption. For Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid, the scale-up step brings surprises. Temperature profiles, pH control at every stage, and agitation rates all have to be monitored more tightly than the bench-top version would suggest. Even a single careless transfer can create an impurity, hiding until a downstream process exposes it. We have added extra in-process checks—HPLC runs at multiple stages and spot-checking final products by NMR and IR—to ensure that the material handed over meets every expectation.

    Differences That Matter in Real-World Use

    Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid often gets compared to standard Fmoc-phenylalanine or Fmoc-4-fluorophenylalanine. But it is not a trivial structural upgrade. That extra methylene shifts both steric and electronic characteristics. In peptide synthesis, these differences demand recalibration of coupling times and sometimes even the selection of coupling reagents. The 4-fluorophenyl group is particularly sensitive in cleavage protocols—acid treatments that work with regular aromatic residues need trial runs with this fluorinated analog. Based on feedback, we routinely test our batches for subtle side reactions, such as out-of-sequence deletions, before any drum leaves the facility. Our hands-on experience becomes our customers’ insurance policy.

    Why Attention to Details in Handling Makes or Breaks the Process

    In daily operations, small factors dictate how this product reaches peptide labs in optimal condition. We only use containers that minimize static build-up and moisture ingress, and we seal every drum with desiccant packs based on batch-specific water content. Staff monitor the oxygen levels in packing rooms, since oxidation of the Fmoc-protected intermediates can accelerate if atmosphere control lapses. We treat humidity as a silent adversary—during rainy seasons, room dehumidifiers work overtime and every shipment undergoes extra inspection. From weighing powders to labeling lots, we teach every technician that careless handling leaves its mark, especially with an Fmoc-protected amino acid in the foreground.

    Roots in Classic Organic Chemistry, Eyes on the Future

    Crafting Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid traces its lineage to the earliest days of peptide chemistry, when teams fought through by hand what is now handled by automated synthesizers. Each reaction along the route bridges tradition and progress. We still respect the classic amide coupling chemistry and keep tabs on emerging options for greener purification. Many customers, especially those in early-stage pharma research, share their interest in less hazardous solvents and minimal waste. Our plant trials focus on adapting flow chemistry and more selective crystallizations, trimming residual solvent levels batch after batch.

    Feedback and Its Role in Everyday Progress

    Direct contact with customers adds a pragmatic perspective to production. When a major university lab asked about trace metal content, we invested in better batchwise ICP-OES testing. When a pharmaceutical startup needed different mesh sizes, we experimented with sieving setups to extend our size range. Lab managers told us how even slight differences in powder density or sensitivity during Fmoc deprotection could trouble process reliability, so we now keep sample vials of each lot for at least a year—any complaint can be matched to its source and cross-checked at the bench.

    Comparing Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid to Other Building Blocks

    With hundreds of Fmoc amino acids on the market, users can only appreciate their real differences during peptide assembly or biological testing. Laboratory teams comment how this compound’s additional fluorine makes a peptide more resistant to degradation in biological fluids. Unlike simple Fmoc-Phe or Fmoc-4F-Phe, the elongated side chain of Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid unlocks selectivity in enzyme testing and can serve as a probe in SAR studies. The S-enantiomer enhances interactions at chiral receptors, a point not captured by simply listing optical rotation or chiral purity. We have heard these distinctions from researchers time and again.

    Safety, Sustainability, and Consistency

    Producing this compound means more than ticking compliance boxes. Our facility integrates safety at every stage, driven by both personal motivation and regulatory obligations. Employees challenge process steps that generate excessive waste or emit volatile organic compounds. Over the past two years, modifications in purification routes have reduced our solvent consumption per kilogram of product by more than 20 percent. We send waste streams to accredited treatment facilities and monitor energy consumption per batch. What motivates these improvements is a daily realization—people who make the product also live near the plant and value the shared environment.

    Supply Reliability: Meeting Demand with Confidence

    During industry upswings, shortages of Fmoc-protected intermediates can throttle research pipelines. We’ve felt these pressures and invested in maintaining a minimum reserve of raw materials, especially specialty fluoro reagents, to buffer unforeseen supplier delays. Automated inventory systems matched with overcapacity blending tanks allow us to handle surges in orders, keeping lot-to-lot consistency steady even across large campaign runs. Customer trust builds batch by batch, and we know retention depends on delivering exactly what was promised, month after month.

    Storage, Transportation, and Delivering a Solid Product

    All the chemistry, quality checks, and clean packaging come to nothing if transport or storage falters. Peptide manufacturers need Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid to arrive dry, powdery, and without surprises. Our warehouse staff follows protocols for refrigeration and light protection, using temperature loggers inside major shipments to historical monitor accidental exposure. Traceability means every drum can be back-tracked to its exact production campaign. We regularly cross-train logistics and production staff, ensuring everyone knows that a small lapse—an unsealed bag or a mixed-up batch—ripples all the way through the synthetic process of the end user.

    Ongoing Improvements: Systems, People, and Performance

    Innovation at a chemical manufacturer runs on both formal R&D projects and informal knowledge sharing. We treat even minor deviations as opportunities to re-examine SOPs. Teams capture lessons in shared logs, and manufacturing leaders meet monthly to review problem spots flagged by facilities, QC, or direct client queries about Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid. Incremental improvements—better fine filtration, tweaks to pH holds, or training sessions on Fmoc cleavage chemistry—keep us ahead of brewing issues and surface hidden inefficiencies that traditional batch reporting would miss.

    Trust, Built Chemistry by Chemistry

    Working at the source, we know every customer contact carries a personal reputation. We don’t offer promises we can’t prove. Every order of Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid is backed by hands-on accountability—if any issue arises, lab head to plant manager will review it, and we’ll pull records, samples, and, if need be, set up a new batch. Most improvements come not from management mandates but from practical exchanges—seeing a rerun outstrip the original by yield or purity. Remaining open to feedback, fast to fix any slip, and always learning from process and partners keeps our production sharp and dependable.

    Looking Forward: Serving Ever-Expanding Needs

    Research in peptidomimetics, drug and probe design, and novel ligand studies continues to push demand for advanced building blocks like this one. We see rising interest not only from synthetic organic chemists but also from biologists who want to customize peptide libraries, screen for new activities, or study subtle receptor interactions using fluorine as a bioisosteric probe. These needs bring new technical challenges—finer enantiomeric purity, lower trace element levels, extra stability in storage—and keeping pace means revisiting each production stage with fresh eyes and open communication channels with both suppliers and users.

    A Manufacturer’s Perspective: Respecting the Science, Honoring the Process

    Producing Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid is a daily reminder that innovation rests on hard-won process understanding, respect for the collaborative nature of chemical manufacturing, and a steady, customer-focused approach to improvement. Our experience on the production floor gives us a vantage point for both problems and practical solutions—one not available from behind a desk or filtered through a distributor’s catalog. Feedback shapes our methods, scientific diligence underpins every lot, and our commitment to quality never wavers.

    Final Observations: Serving People, Not Just Pipelines

    We make Fmoc-(S)-3-Amino-4-(4-Fluoro-Phenyl)-Butyric Acid to enable creative, world-changing discoveries in medicines and beyond. Our daily work is more than chemistry—it’s about building partnerships with researchers, understanding the small frustrations in a synthetic workflow, and helping teams hit timelines and quality targets. Open conversations and transparent data-sharing with our users makes this more than a transaction—it becomes a shared journey to better, safer, and more powerful science. Every improvement, whether in process control, user support, or safe delivery, emerges from this long-term partnership approach. That’s how we keep advancing with our customers and make sure that every box of product shipped carries not just a certificate but also our personal commitment to reliability and progress.